TechnoPhage is currently working on several projects in different therapeutic areas, such as infection, ophthalmology, or neuroscience, among which numerous patents have been placed throughout the years. Did you know that the total number of ‘live’ patents...
This year Technophage has been featured in the Portuguese edition of The Business Year. The publication was based on more than 130 face-to-face interviews with leading #investors, business leaders, and government representatives from all the key sectors driving...
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2022’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC Innovative Status...
Technophage’s plans for the next few years have been revealed in a brand new article in Portuguese Weekly Journal “Expresso”. The biopharma is moving forward with the creation of a new company that will be able to ensure the industrialization of pioneering drugs for...
During the development of TP-102 a lot of journals published pieces describing this great Technophage’s milestone. This year, Jornal Expresso, described the efforts made by the company to reach Phase I/IIa Clinical Trial with TP-102 in Israel. If you did not get...
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2021’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC...
